CSCO长期致力于开展临床肿瘤学继续教育和多中心协作研究,推动肿瘤诊断治疗的规范化,提高中国临床肿瘤学的学术水平。 2022中国临床肿瘤学会(CSCO)乳腺癌诊疗指南推荐多基因表达谱检测(21基因复发风险评估、70基因检测)、ER、PR、HER2、Ki-67分子特征检测、推荐PD-L1表达检测,同时推荐对遗传性乳腺高危患者进行遗传学咨询。
NCCN GUIDELINES ® 2022 FOR PATIENTS Breast Cancer Metastatic Presented with support from: Available online at NCCN.org/patients Ü Metastatic Breast Cancer Its easy to get lost in the cancer world Let NCCN Guidelines for Patients® be your guide 9 Step-by-step guides to the cancer ...
1.Sacituzumab govitecan-hziy (Trodelvy) elevated to category 1 preferred recommendation in second-line metastatic triple-negative breast cancer and added as a category 2a preferred recommendation for HR+/HER2- metastatic breast ...
j.Yancy CW, Jessup M, Bozkurt B, et al. 2013 ACCF/AHA guideline for the management of heart failure: a report of the Amercian College of Cardiology Foundation/American Heart Association Task Force on practice guidelines. Circulation 2013;128:e240-...
检测方法:FISH、NGS、PCR FDA批准药物:拉罗替尼、恩曲替尼 5. TMB(≥10mut/mb) 检测方法:NGS FDA批准药物:帕博利珠单抗 参考资料: 1.中国临床肿瘤学会(CSCO)乳腺癌诊疗指南2022 2.NCCN Guidelines Version 4.2022 Breast Cancer. 作者:医世象 叶子
Patients with a known genetic predisposition to breast cancer p53基因病理突变(利-弗劳梅尼综合征)(2B类)(参见NCCN遗传/家族高风险评定指南:乳腺癌、卵巢癌和胰腺癌) Pathologic p53 mutation (Li-Fraumeni syndrome) (category 2B) (See NCCN Guidelines for Genetic/Familial High-Risk Assessment: Breast, Ovar...
GAST-1 版本 2.2022, 01/11/22 © 2022 National Comprehensive Cancer Network® (NCCN®), 保留所有权利. 未经 NCCN 明确书面许可,不得以任何形式对本NCCN Guidelines® 及其插图进行复制。 NCCN Guidelines 版本 2.2022 NCCN Guidelines 索引 目录 胃癌 讨论 GAST-1的脚注 a 参见内镜分期和治疗原则 (...
版权归©2022NationalComprehensiveCancerNetwork,Inc公司所有。NCCNGuidelinesVersion2.2022乳腺癌NCCN乳腺癌小组成员指南更新概要从NCCN乳腺癌指南中删除了小叶原位癌的建议,参见NCCN乳腺筛查和诊断指南非浸润性乳腺癌:导管原位癌(DCIS)检查和初始治疗(DCIS-1)DCIS术后治疗和监测/随访(DCIS-2)浸润性乳腺癌:临床分期,检查(...
Imaging, 3rd bullet added:For patients with germline mutations or family history of breast cancer, please refer to See NCCN Guidelines for Genetic/Familial High-Risk Assessment: Breast, Ovarian, and Pancreatic 新增:治疗后监测 Added:Post treatment monitoring ...
[1] 肖玉铃,朱秀之,江一舟,等.三阴性乳腺癌精准治疗研究的新进展与未来展望[J].中国癌症杂志,2022,32(08):669-679. [2] National Comprehensive Cancer Network (NCCN). NCCN Clinical Practice Guidelines in Oncology: Breast Cancer (2023 Version 3)[internet]; 2023. Available from: https://www.nccn....